| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Email: |
sales@dcchemicals.com |
| Products Intro: |
Product Name:SGL5213
CAS:1240305-17-2
Purity:98% HPLC Package:100mg，250mg，1g
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
| Products Intro: |
Product Name:SGL5213
CAS:1240305-17-2
Purity:98% Package:5mg；10mg；20mg；50mg；100mg；200mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:SGL5213
CAS:1240305-17-2
Package:100mg;50mg;25mg
|
| Company Name: |
Adooq Bioscience LLC
|
| Tel: |
400-025-6535 |
| Email: |
sales@adooq.cn |
| Products Intro: |
Product Name:SGL5213
CAS:1240305-17-2
|
|
| | SGL5213 Basic information |
| Product Name: | SGL5213 | | Synonyms: | 3-Butenamide, N-[2-[[2-(dimethylamino)ethyl]amino]-1,1-dimethyl-2-oxoethyl]-4-[4-[[5-β-D-glucopyranosyl-4-methoxy-2-(1-methylethyl)phenyl]methyl]phenyl]-2,2-dimethyl-, (3E)-;SGL5213;SGL-5213,SGL5213 | | CAS: | 1240305-17-2 | | MF: | C37H55N3O8 | | MW: | 669.85 | | EINECS: | | | Product Categories: | | | Mol File: | 1240305-17-2.mol |  |
| | SGL5213 Chemical Properties |
| Boiling point | 871.2±65.0 °C(Predicted) | | density | 1.182±0.06 g/cm3(Predicted) | | pka | 13.32±0.70(Predicted) |
| | SGL5213 Usage And Synthesis |
| Uses | SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment[1]. | | References | [1] Kuroda S, et al. Discovery of potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor SGL5213 for type 2 diabetes treatment. Bioorg Med Chem. 2019 Jan 15;27(2):394-409. DOI:10.1016/j.bmc.2018.12.015 |
| | SGL5213 Preparation Products And Raw materials |
|